NRBO Insider Transactions
| Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2022-07-26 | E&Investment, Inc. | 10 percent owner | 2,890,533 | J-Other | D | 1,445,267 | 0.00 | 0.00 |
| 2022-07-26 | Kim Na Yeon | director, 10 percent owner | 2,890,533 | J-Other | D | 1,445,267 | 0.00 | 0.00 |
| 2022-06-09 | GROVES JASON L | director | 20,000 | A-Award | A | 20,000 | 0.47 | 9,450.00 |
| 2022-06-09 | Kim Na Yeon | director, 10 percent owner | 20,000 | A-Award | A | 20,000 | 0.47 | 9,450.00 |
| 2022-06-09 | Kim Hyung Heon | director | 20,000 | A-Award | A | 20,000 | 0.47 | 9,450.00 |
| 2022-06-09 | Kang Richard | director | 20,000 | A-Award | A | 20,000 | 0.47 | 9,450.00 |
| 2022-06-09 | STRICKLAND D GORDON | director | 20,000 | A-Award | A | 20,000 | 0.47 | 9,450.00 |
| 2022-06-09 | KOVEN ANDREW I | director | 20,000 | A-Award | A | 20,000 | 0.47 | 9,450.00 |
| 2022-06-09 | Salsbury Michael | director | 20,000 | A-Award | A | 20,000 | 0.47 | 9,450.00 |
| 2022-01-27 | STRICKLAND D GORDON | director | 40,000 | A-Award | A | 40,000 | 1.02 | 40,800.00 |
| 2021-11-03 | Price Ben Gil | officer: CEO and President | 616,666 | A-Award | A | 616,666 | 2.04 | 1,257,998.64 |
| 2021-09-02 | KOVEN ANDREW I | director | 60,000 | A-Award | A | 60,000 | 4.52 | 271,200.00 |
| 2020-12-31 | Bakshi Akash | director, officer: SVP and COO | 884,072 | A-Award | A | 855,059 | 0.00 | 0.00 |
| 2020-12-31 | Bakshi Akash | director, officer: SVP and COO | 29,013 | A-Award | A | 29,013 | 0.00 | 0.00 |
| 2020-09-01 | Swirsky Douglas J | director | 60,000 | A-Award | A | 60,000 | 6.04 | 362,400.00 |
| 2020-01-13 | Salsbury Michael | director | 60,000 | A-Award | A | 60,000 | 8.39 | 503,400.00 |
| 2020-01-13 | Oh Jeong Gyun | director, 10 percent owner | 60,000 | A-Award | A | 60,000 | 8.39 | 503,400.00 |
| 2020-01-13 | GROVES JASON L | director | 60,000 | A-Award | A | 60,000 | 8.39 | 503,400.00 |
| 2020-01-13 | Jeong Tae Heum | director | 60,000 | A-Award | A | 60,000 | 8.39 | 503,400.00 |
| 2020-01-13 | Kim Na Yeon | director, 10 percent owner | 60,000 | A-Award | A | 60,000 | 8.39 | 503,400.00 |
| 2020-01-13 | Gullans Steven R. Ph.D. | director | 60,000 | A-Award | A | 60,000 | 8.39 | 503,400.00 |
| 2019-12-30 | Kim Na Yeon | director, 10 percent owner | 4,335,800 | A-Award | A | 4,335,800 | 0.00 | 0.00 |
| 2019-12-30 | Kim Na Yeon | director, 10 percent owner | 1,121,190 | A-Award | A | 1,121,190 | 0.00 | 0.00 |
| 2019-12-30 | Kim Na Yeon | director, 10 percent owner | 1,864,799 | A-Award | A | 1,864,799 | 0.00 | 0.00 |
| 2019-12-30 | Oh Jeong Gyun | director, 10 percent owner | 1,817,842 | A-Award | A | 1,817,842 | 0.00 | 0.00 |
| 2019-12-30 | Oh Jeong Gyun | director, 10 percent owner | 240,051 | A-Award | A | 240,051 | 0.00 | 0.00 |
| 2019-12-30 | Versavel Mark | officer: Chief Medical Officer | 297,206 | A-Award | A | 297,206 | 0.00 | 0.00 |
| 2019-12-30 | Versavel Mark | officer: Chief Medical Officer | 45,724 | A-Award | A | 45,724 | 0.00 | 0.00 |
| 2019-07-24 | Gullans Steven R. Ph.D. | director | 300,000 | A-Award | A | 300,000 | 0.00 | 0.00 |
| 2019-07-24 | SASSINE ANDY | director | 151,264 | A-Award | A | 15,000 | 0.00 | 0.00 |
| 2019-07-24 | LICHTINGER PEDRO | director | 74,833 | A-Award | A | 15,000 | 0.00 | 0.00 |
| 2019-07-24 | KOUSKY KENNETH W | director | 26,935 | A-Award | A | 15,000 | 0.00 | 0.00 |
| 2019-07-24 | Reno Seth | officer: Chief Commercial Officer | 118,286 | A-Award | A | 100,000 | 0.00 | 0.00 |
| 2019-07-24 | Bisgaier Charles PhD | director, 10 percent owner, officer: Chief Scientific Off. & Chair | 1,348,914 | A-Award | A | 100,000 | 0.00 | 0.00 |
| 2018-05-22 | Gullans Steven R. Ph.D. | director | 50,000 | A-Award | A | 50,000 | 5.56 | 278,000.00 |
| 2018-05-01 | Gullans Steven R. Ph.D. | director | 150,000 | A-Award | A | 150,000 | 5.56 | 834,000.00 |
| 2018-02-08 | Reno Seth | officer: Chief Commercial Officer | 18,286 | P-Purchase | A | 14,286 | 7.00 | 100,002.00 |
| 2018-02-08 | Gullans Steven R. Ph.D. | director | 930,252 | P-Purchase | A | 71,429 | 7.00 | 500,003.00 |
| 2018-01-29 | Hawryluk P. Kent | director | 10,800 | A-Award | A | 10,800 | 10.44 | 112,752.00 |
| 2018-01-29 | Gullans Steven R. Ph.D. | director | 60,000 | A-Award | A | 60,000 | 10.44 | 626,400.00 |
| 2018-01-29 | SASSINE ANDY | director | 10,800 | A-Award | A | 10,800 | 10.44 | 112,752.00 |
| 2018-01-29 | LICHTINGER PEDRO | director | 10,800 | A-Award | A | 10,800 | 10.44 | 112,752.00 |
| 2018-01-29 | KOUSKY KENNETH W | director | 10,800 | A-Award | A | 10,800 | 10.44 | 112,752.00 |
| 2018-01-28 | Reno Seth | officer: Chief Commercial Officer | 48,000 | A-Award | A | 48,000 | 10.10 | 484,800.00 |
| 2018-01-28 | MATHIESEN JEFFREY S | officer: Chief Financial Officer | 48,000 | A-Award | A | 48,000 | 10.10 | 484,800.00 |
| 2018-01-28 | Golden Lee Scott | officer: Chief Medical Officer | 148,000 | A-Award | A | 148,000 | 10.10 | 1,494,800.00 |
| 2018-01-28 | Bisgaier Charles PhD | director, 10 percent owner, officer: Chief Scientific Off. & Chair | 48,000 | A-Award | A | 48,000 | 10.10 | 484,800.00 |
| 2017-08-14 | MATHIESEN JEFFREY S | officer: Chief Financial Officer | 14,134 | M-Exempt | A | 3,207 | 3.59 | 11,513.13 |
| 2017-08-14 | MATHIESEN JEFFREY S | officer: Chief Financial Officer | 0 | M-Exempt | D | 3,207 | 3.59 | 11,513.13 |
| 2017-08-10 | MATHIESEN JEFFREY S | officer: Chief Financial Officer | 10,927 | M-Exempt | A | 3,000 | 3.59 | 10,770.00 |
| 2017-08-10 | MATHIESEN JEFFREY S | officer: Chief Financial Officer | 0 | M-Exempt | D | 3,000 | 3.59 | 10,770.00 |
| 2017-08-10 | MATHIESEN JEFFREY S | officer: Chief Financial Officer | 45,093 | M-Exempt | D | 3,000 | 3.59 | 10,770.00 |
| 2017-07-31 | Bisgaier Charles PhD | director, 10 percent owner, officer: Chief Scientific Off. & Chair | 1,248,914 | M-Exempt | A | 4,474 | 1.34 | 6,013.06 |
| 2017-07-31 | Bisgaier Charles PhD | director, 10 percent owner, officer: Chief Scientific Off. & Chair | 0 | M-Exempt | D | 4,474 | 1.34 | 6,013.06 |
| 2017-05-30 | Gullans Steven R. Ph.D. | director | 60,000 | A-Award | A | 60,000 | 10.26 | 615,600.00 |
| 2017-03-28 | Golden Lee Scott | officer: Chief Medical Officer | 20,000 | A-Award | A | 20,000 | 11.15 | 223,000.00 |
| 2017-03-10 | Gullans Steven R. Ph.D. | director | 858,823 | P-Purchase | A | 52,798 | 9.47 | 499,997.06 |
| 2017-03-10 | Gullans Steven R. Ph.D. | director | 39,599 | P-Purchase | A | 39,599 | 10.40 | 411,829.60 |
| 2017-03-10 | SASSINE ANDY | director | 136,264 | P-Purchase | A | 21,119 | 9.47 | 199,996.93 |
| 2017-03-10 | SASSINE ANDY | director | 15,840 | P-Purchase | A | 15,840 | 10.40 | 164,736.00 |
| 2017-03-10 | LICHTINGER PEDRO | director | 59,833 | P-Purchase | A | 10,559 | 9.47 | 99,993.73 |
| 2017-03-10 | LICHTINGER PEDRO | director | 7,920 | P-Purchase | A | 7,920 | 10.40 | 82,368.00 |
| 2017-03-10 | Hawryluk P. Kent | director | 81,889 | P-Purchase | A | 25,000 | 9.47 | 236,750.00 |
| 2017-03-10 | Hawryluk P. Kent | director | 18,750 | P-Purchase | A | 18,750 | 10.40 | 195,000.00 |
| 2017-02-01 | KOUSKY KENNETH W | director | 6,463 | J-Other | D | 110,428 | 0.00 | 0.00 |
| 2017-02-01 | KOUSKY KENNETH W | director | 4,472 | J-Other | D | 101,406 | 0.00 | 0.00 |
| 2016-11-25 | Sooch Mina | director, officer: President & CEO | 600,000 | A-Award | A | 120,000 | 10.00 | 1,200,000.00 |
| 2016-10-05 | Golden Lee Scott | officer: Chief Medical Officer | 126,000 | A-Award | A | 126,000 | 10.80 | 1,360,800.00 |
| 2016-09-30 | Sooch Mina | director, officer: President & CEO | 480,000 | A-Award | A | 120,000 | 10.00 | 1,200,000.00 |
| 2016-08-10 | Bisgaier Charles PhD | director, 10 percent owner, officer: Chief Scientific Off. & Chair | 19,228 | C-Conversion | A | 19,228 | 6.71 | 128,941.05 |
| 2016-08-10 | Oniciu Carmen Daniela | officer: Vice President | 152,156 | C-Conversion | A | 2,237 | 0.00 | 0.00 |
| 2016-08-10 | Sooch Mina | director, officer: President & CEO | 0 | C-Conversion | D | 11,078 | 6.71 | 74,287.96 |
| 2016-08-10 | KOUSKY KENNETH W | director | 105,878 | J-Other | A | 10,439 | 6.71 | 70,002.89 |
| 2016-08-10 | Hawryluk P. Kent | director | 56,889 | P-Purchase | A | 25,000 | 10.00 | 250,000.00 |
| 2016-08-10 | Hawryluk P. Kent | director | 7,457 | C-Conversion | A | 7,457 | 6.71 | 50,005.90 |
| 2016-08-10 | SASSINE ANDY | director | 83,292 | J-Other | A | 8,212 | 6.71 | 55,068.85 |
| 2016-08-10 | Hawryluk P. Kent | director | 8,273 | J-Other | A | 816 | 6.71 | 5,472.01 |
| 2016-08-10 | LICHTINGER PEDRO | director | 39,274 | C-Conversion | A | 39,274 | 6.71 | 263,367.52 |
| 2016-08-10 | LICHTINGER PEDRO | director | 49,274 | P-Purchase | A | 10,000 | 10.00 | 100,000.00 |
| 2016-08-10 | Gullans Steven R. Ph.D. | director | 806,025 | P-Purchase | A | 500,000 | 10.00 | 5,000,000.00 |
| 2016-08-10 | Gullans Steven R. Ph.D. | director | 306,025 | C-Conversion | A | 306,025 | 6.71 | 2,052,173.05 |
| 2016-08-10 | KOUSKY KENNETH W | director | 95,439 | C-Conversion | A | 95,439 | 6.71 | 640,004.39 |
| 2016-08-10 | KOUSKY KENNETH W | director | 116,891 | C-Conversion | A | 116,891 | 6.71 | 783,859.36 |
| 2016-08-10 | KOUSKY KENNETH W | director | 1,000 | P-Purchase | A | 1,000 | 10.00 | 10,000.00 |
| 2016-08-10 | KOUSKY KENNETH W | director | 0 | C-Conversion | D | 95,439 | 6.71 | 640,004.39 |
| 2016-08-10 | Hawryluk P. Kent | director | 0 | C-Conversion | D | 7,457 | 6.71 | 50,005.90 |
| 2016-08-10 | Hawryluk P. Kent | director | 31,889 | C-Conversion | A | 23,616 | 6.71 | 158,366.53 |
| 2016-08-10 | SASSINE ANDY | director | 75,080 | C-Conversion | A | 75,080 | 6.71 | 503,478.97 |
| 2016-08-10 | SASSINE ANDY | director | 115,145 | C-Conversion | A | 31,853 | 6.71 | 213,603.03 |
| 2016-08-10 | SASSINE ANDY | director | 0 | C-Conversion | D | 75,080 | 6.71 | 503,478.97 |
| 2016-08-10 | Reno Seth | officer: Chief Commercial Officer | 4,000 | P-Purchase | A | 4,000 | 10.00 | 40,000.00 |
| 2016-08-10 | Bisgaier Charles PhD | director, 10 percent owner, officer: Chief Scientific Off. & Chair | 1,244,440 | P-Purchase | A | 51,750 | 10.00 | 517,500.00 |
| 2016-08-10 | Bisgaier Charles PhD | director, 10 percent owner, officer: Chief Scientific Off. & Chair | 82,220 | C-Conversion | A | 16,144 | 6.71 | 108,260.05 |
| 2016-08-10 | Bisgaier Charles PhD | director, 10 percent owner, officer: Chief Scientific Off. & Chair | 66,076 | J-Other | A | 6,515 | 6.71 | 43,688.94 |
| 2016-08-10 | Bisgaier Charles PhD | director, 10 percent owner, officer: Chief Scientific Off. & Chair | 59,561 | C-Conversion | A | 59,561 | 6.71 | 399,410.11 |
| 2016-08-10 | Bisgaier Charles PhD | director, 10 percent owner, officer: Chief Scientific Off. & Chair | 0 | C-Conversion | D | 59,561 | 6.71 | 399,410.11 |
| 2016-08-10 | Sooch Mina | director, officer: President & CEO | 12,290 | J-Other | A | 1,212 | 6.71 | 8,127.55 |
| 2016-08-10 | Sooch Mina | director, officer: President & CEO | 11,078 | C-Conversion | A | 11,078 | 6.71 | 74,287.96 |
| 2016-08-10 | Sooch Mina | director, officer: President & CEO | 693,732 | P-Purchase | A | 52,500 | 10.00 | 525,000.00 |
| 2016-08-10 | Sooch Mina | director, officer: President & CEO | 39,431 | C-Conversion | A | 27,141 | 6.71 | 182,004.83 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.